A novel serum metabolite classifier for identifying Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) integrating metabolomics and machine learning.

Furthermore, although the serum levels of AST, TBIL, DBIL and total TC were higher in the MASLD group compared to the healthy control group, these differences did not reach statistical significance.

also in 111,027 other papers